LITTLE FALLS, N.J.,
Jan. 7, 2013 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMN) announced today
that Andrew A. Krakauer, President
& CEO, will be presenting at the Needham 15th Annual
Growth Conference. The formal presentation is scheduled for
2:50 PM ET on Thursday, January 17, 2013 at The New York Palace
Hotel, with a Q & A session immediately following the
presentation. In addition, Mr. Krakauer and Seth Yellin, Vice President-Corporate
Development, will be available for separate one-on-one meetings
during the day. The presentation will be available on the Investor
Relations section of the Company's website:
www.cantelmedical.com.
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:
CMN) is a leading provider of infection prevention and control
products in the healthcare market. Our products include water
purification equipment, sterilants, disinfectants and cleaners,
specialized medical device reprocessing systems for endoscopy and
renal dialysis, disposable infection control products primarily for
dental and GI endoscopy markets, dialysate concentrates and other
dialysis supplies, hollow fiber membrane filtration and separation
products for medical and non-medical applications, and specialty
packaging for infectious and biological specimens. We also provide
technical maintenance for our products and offer compliance
training services for the transport of infectious and biological
specimens. For further information, visit the Cantel website
at http://www.cantelmedical.com.
SOURCE Cantel Medical Corp.